Entera Bio (ENTX) Ownership - Who owns Entera Bio?
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENTX showed earnings on May 09, 2025. You can read more about the earnings report here.